ask="2.980"
ask_size="1100"
average_daily_volume="3617770"
bid="2.930"
bid_size="2000"
book_value="-1.752"
change="-0.095"
change_from_200_day_moving_average="-1.732"
change_from_50_day_moving_average="-0.162"
change_from_52_week_high="-6.040"
change_From_52_week_low="0.145"
change_in_percent="-3.094%"
close="2.975"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.372"
ebitda="-120.56M"
eps_estimate_current_year="-1.160"
eps_estimate_next_quarter="-0.100"
eps_estimate_next_year="-0.230"
ex_dividend_date="N/A"
float_shares="113594000"
high="3.150"
high_52_weeks="9.015"
last_trade_date="3/1/2017"
last_trade_price="2.975"
last_trade_size="85296"
last_trade_time="4:00pm"
low="2.900"
low_52_weeks="2.830"
market_capitalization="385.60M"
moving_average_200_day="4.707"
moving_average_50_day="3.137"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.000"
open="3.150"
pe_ratio="N/A"
peg_ratio="-0.470"
percent_change_from_200_day_moving_average="-36.794%"
percent_change_from_50_day_moving_average="-5.166%"
percent_change_from_52_week_high="-66.999%"
percent_change_from_52_week_low="+5.124%"
previous_close="3.070"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.810"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="4.680"
stock_exchange="NGM"
symbol="MACK"
volume="5341060"
weeks_range_52="2.830 - 9.015"
